Testosterone and sex hormone-binding globulin have significant association with metabolic syndrome in Taiwanese men

References

• Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome–a new worldwide definition. Lancet 2005;366:1059–1062.
   PubMed Web of Science ®Google Scholar
• Rolf C, Nieschlag E. Potential adverse effects of long-term testosterone therapy. Baillieres Clin Endocrinol Metab 1998;12:521–534.
   PubMedGoogle Scholar
• Stergiopoulos K, Brennan JJ, Mathews R, Setaro JF, Kort S. Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature. Vasc Health Risk Manag 2008;4:1475–1480.
   PubMedGoogle Scholar
• Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 1997;146:609–617.
   PubMed Web of Science ®Google Scholar
• Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 2011;40:189–207.
   PubMed Web of Science ®Google Scholar
• Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006;91:843–850.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR, Andres R. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 2007;92:3568–3572.
   PubMed Web of Science ®Google Scholar
• Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006;60:762–769.
   PubMed Web of Science ®Google Scholar
• Litman HJ, Bhasin S, Link CL, Araujo AB, McKinlay JB. Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab 2006;91:4326–4334.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, et al.; EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123–135.
   PubMed Web of Science ®Google Scholar
• Li C, Ford ES, Li B, Giles WH, Liu S. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 2010;33:1618–1624.
   PubMed Web of Science ®Google Scholar
• Ganesh HK, Vijaya Sarathi HA, George J, Shivane VK, Bandgar T, Menon PS, Shah NS. Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group. Endocr Pract 2009;15:513–520.
   PubMedGoogle Scholar
• Yeh HC, Wang CJ, Lee YC, Hsiao HL, Wu WJ, Chou YH, Huang CH. Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. Kaohsiung J Med Sci 2008;24:240–247.
   PubMed Web of Science ®Google Scholar
• Tang YJ, Lee WJ, Chen YT, Liu PH, Lee MC, Sheu WH. Serum testosterone level and related metabolic factors in men over 70 years old. J Endocrinol Invest 2007;30:451–458.
   PubMed Web of Science ®Google Scholar
• Tong PC, Ho CS, Yeung VT, Ng MC, So WY, Ozaki R, Ko GT, et al. Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes. J Clin Endocrinol Metab 2005;90:6418–6423.
   PubMed Web of Science ®Google Scholar
• Akishita M, Fukai S, Hashimoto M, Kameyama Y, Nomura K, Nakamura T, Ogawa S, et al. Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men. Hypertens Res 2010;33:587–591.
   PubMed Web of Science ®Google Scholar
• Katabami T, Kato H, Asahina T, Hinohara S, Shin T, Kawata T, Ohta A, et al. Serum free testosterone and metabolic syndrome in Japanese men. Endocr J 2010;57:533–539.
   PubMed Web of Science ®Google Scholar
• Lin MS, Shih SR, Li HY, Chuang LM, Chang TC, Wei JN, Shieh GJ, et al. Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men. Diabetes Res Clin Pract 2007;77:286–292.
   PubMedGoogle Scholar
• Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12.
   PubMed Web of Science ®Google Scholar
• Liao CH, Li HY, Chung SD, Chiang HS, Yu HJ. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40–79 years. Aging Male. 2011 [Epub ahead of print].
   Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–3672.
   PubMed Web of Science ®Google Scholar
• Allan CA, McLachlan RI. Androgens and obesity. Curr Opin Endocrinol Diabetes Obes 2010;17:224–232.
   PubMed Web of Science ®Google Scholar
• Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB. Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 2008;93:3403–3410.
   PubMed Web of Science ®Google Scholar
• Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006;105:626–635.
   PubMed Web of Science ®Google Scholar
• Lin CC, Liu CS, Lai MM, Li CI, Chen CC, Chang PC, Lin WY, et al. Metabolic syndrome in a Taiwanese metropolitan adult population. BMC Public Health 2007;7:239.
   PubMedGoogle Scholar
• Lai SW, Liao KF, Li TC, Lin HF, Lin WY, Lin CH. Metabolic syndrome in older people in Taiwan: a hospital-based study. Intern Med J 2006;36:648–651.
   PubMed Web of Science ®Google Scholar
• Chubb SA, Hyde Z, Almeida OP, Flicker L, Norman PE, Jamrozik K, Hankey GJ, Yeap BB. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol 2008;158:785–792.
   PubMed Web of Science ®Google Scholar
• Pi-Sunyer FX. Androgens and body fat distribution in men. Obes Res 1993;1:303–305.
   PubMedGoogle Scholar
• Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med 2008;8:816–828.
   PubMedGoogle Scholar
• Lakshman KM, Bhasin S, Araujo AB. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci 2010;65:503–509.
   PubMed Web of Science ®Google Scholar
• Shakir YA, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C, Agardh CD. Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women’s Health in the Lund Area (WHILA) Study. Fertil Steril 2007;88:163–171.
   PubMedGoogle Scholar
• Jones RD, Nettleship JE, Kapoor D, Jones HT, Channer KS. Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs 2005;5:141–154.
   PubMedGoogle Scholar
• Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 2005;90:2618–2623.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–2752.
   PubMed Web of Science ®Google Scholar